Showing 3551-3560 of 19355 results for "".
The Role of Hemodynamics for AKI and Maintaining Hemodynamic Stability in KRT Patients
https://reachmd.com/programs/kdigo-conversations-nephrology/the-role-of-hemodynamics-for-aki-and-maintaining-hemodynamic-stability-in-krt-patients/14170/What is the role of hemodynamics in patients with acute kidney injury? And why is it important to maintain hemodynamic stability during KRT?Management of POSEIDON Groups 3-4
https://reachmd.com/programs/global-womens-health-academy/management-poseidon-groups-3-4/9919/Dr. Humaidan presents the POSEIDON classification, including detailed discussion of groups 3 and 4.Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
https://reachmd.com/programs/cme/navigating-treatment-sequencing-after-frontline-treatment-failure-in-cll/39260/Dr. Jennifer Brown discusses CLL treatment sequencing after frontline failure, including resistance vs intolerance, MRD-guided strategies, and second-line therapy decisions.Optimizing Barostim Outcomes: Practical Approaches to Patient Selection and Monitoring
https://reachmd.com/programs/cme/optimizing-barostim-outcomes-practical-approaches-to-patient-selection-and-monitoring/29819/Explore best practices for talking to patients about their QoL and successfully identifying appropriate candidates for treatment with Barostim.Test Your Skills and Learn From Experts on Best Practice in Diagnosis and Management of Systemic Mastocytosis
https://reachmd.com/programs/cme/test-your-skills-and-learn-from-experts-on-best-practice-in-diagnosis-and-management-of-systemic-mastocytosis/54694/On-demand webcast featuring expert-informed best practices for diagnosing and managing patients with systemic mastocytosis (SM) as well as the latest data on new and emerging SM therapies.Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
https://reachmd.com/programs/project-oncology/retifanlimab-pod1um-303-subgroups-anal-canal-scc/54279/Subgroup analyses from the phase 3 POD1UM-303/INTERAACT2 trial offer important insights into the use of retifanlimab with carboplatin and paclitaxel for advanced squamous cell carcinoma of the anal canal. Joining Dr. Charles Turck to break down the data is Dr. Marwan Fakih, Professor in the DepartmeThe New POSEIDON Criteria: The WHY, the WHAT, and the HOW
https://reachmd.com/programs/global-womens-health-academy/new-poseidon-criteria-why-what-and-how/9904/Dr. Sandro Esteves reviews the new POSEIDON criteria & discusses innovative alternatives for clinical management.Beyond Lab Values: Understanding Symptom Burden in Primary Biliary Cholangitis
https://reachmd.com/programs/gi-insights/beyond-lab-values-understanding-symptom-burden-in-primary-biliary-cholangitis/54677/Primary biliary cholangitis (PBC) is associated with a significant symptom burden that can profoundly impact patients’ quality of life. Symptoms like fatigue and pruritus are common but often underrecognized, and may persist even when laboratory findings suggest controlled disease. To explore the evTreatment of a Broader Population of Patients With DMD
https://reachmd.com/programs/cme/treatment-of-a-broader-population-of-patients-with-dmd/33167/By completing this activity, learners will gain the skills and confidence to determine therapeutic candidacy and conduct appropriate assessments for patients with Duchenne Muscular Dystrophy (DMD) across the age spectrum, including older and non-ambulatory individuals. They will improve their abilitFSGS in Practice: Patient-Centered Decision-Making
https://reachmd.com/programs/cme/fsgs-in-practice-patient-centered-decision-making/35713/Join our expert nephrology faculty and learn about practical strategies for improving your diagnostic skills and treatment selection in FSGS.